Evidence map›Paper›PMID 33839975›Full record

ArticleAnnals of surgical oncology2021

Limited Resection Versus Pancreaticoduodenectomy for Duodenal Gastrointestinal Stromal Tumors? Enucleation Interferes in the Debate: A European Multicenter Retrospective Cohort Study.

Clément Dubois, Frederiek Nuytens, Hélène Behal, Caroline Gronnier, Gilles Manceau, Maxime Warlaumont, Alain Duhamel, Quentin Denost, Charles Honoré, Olivier Facy and 12 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Primary small bowel malignancies].Chirurgie (Heidelberg, Germany) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 20 institutions in 3 countries.

Clément Dubois *Department of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, CHU de Lille, Lille, France.
Frederiek Nuytens *Department of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, CHU de Lille, Lille, France. frederiek.nuytens@gmail.com.ORCID http://orcid.org/0000-0003-1194-0981
Hélène BehalUniversity Lille, CHU Lille, ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, Lille, France.
Caroline GronnierDepartment of Digestive Surgery, Haut Lévêque University Hospital, Bordeaux, France.
Gilles ManceauDepartment of Digestive Surgery, Pitié-Salpêtrière University Hospital, Paris, France.
Maxime WarlaumontDepartment of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, CHU de Lille, Lille, France.
Alain DuhamelUniversity Lille, CHU Lille, ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, Lille, France.
Quentin DenostDepartment of Digestive Surgery, Haut Lévêque University Hospital, Bordeaux, France.
Charles HonoréDepartment of Surgery, Institut Gustave Roussy, Villejuif, France.
Olivier FacyDepartment of Digestive Surgery, Dijon University Hospital, Dijon, France.
Jean-Jacques TuechDepartment of Digestive Surgery, Charles Nicolle University Hospital, Rouen, France.
Guido TiberioGeneral Surgery, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Cécile BrigandDepartment of Digestive Surgery, Hautepierre University Hospital, Strasbourg, France.
Jean-Pierre BailDepartment of Digestive Surgery, Brest University Hospital, Brest, France.
Ephrem SalameDepartment of Digestive Surgery, Tours University Hospital, Tours, France.
Bernard MeunierDepartment of Digestive Surgery, Pontchailloux University Hospital, Rennes, France.
Jérémie H LefevreDepartment of Digestive Surgery, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France.
Muriel MathonnetDepartment of Digestive Surgery, Limoges University Hospital, Limoges, France.
Mohamed Sbai IdrissiDepartment of Digestive Surgery, Clinique Claude Bernard RAMSAY, Ermont, France.
Florence RenaudDepartment of Pathology, Lille University Hospital, Lille, France.
Guillaume PiessenDepartment of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, CHU de Lille, Lille, France.
AFC and FREGAT Working Group
Sorbonne Université · FRHôpital d'Hautepierre · FRCentre Hospitalier Universitaire de Lille · FRHôpital Cardiologique du Haut-Lévêque · FRHôpital Purpan · FRNantes Université · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Reims · FRCentre Oscar Lambret · FRHôpital Civil, Strasbourg · FRHôpital de la Conception · FRHôpital de la Croix-Rousse · FRHôpital Lyon Sud · FRInfirmerie Protestante · FRInstitute Mutualiste Montsouris · FRUniversité de Rouen Normandie · FRAssociation François Aupetit · FRHôpital Beaujon · FRHôpital de la Timone · FRHôpital Louis-Mourier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal surgical procedure for duodenal gastrointestinal stromal tumors (D-GISTs) remains poorly defined. Pancreaticoduodenectomy (PD) allows for a wide resection but is associated with a high morbidity rate.

objectivesThe aim of this study was to compare the short- and long-term outcomes of PD versus limited resection (LR) for D-GISTs and to evaluate the role of tumor enucleation (EN).

methodsIn this retrospective European multicenter cohort study, 100 patients who underwent resection for D-GIST between 2001 and 2013 were compared between PD (n = 19) and LR (n = 81). LR included segmental duodenectomy (n = 47), wedge resection (n = 21), or EN (n = 13). The primary objective was to evaluate disease-free survival (DFS) between the groups, while the secondary objectives were to analyze the overall morbidity and mortality, radicality of resection, and 5-year overall survival (OS) and recurrence rates between groups. Furthermore, the short- and long-term outcomes of EN were evaluated.

resultsBaseline characteristics were comparable between the PD and LR groups, except for a more frequent D2 tumor location in the PD group (68.3% vs. 29.6%; p = 0.016). Postoperative morbidity was higher after PD (68.4% vs. 23.5%; p < 0.001). OS (p = 0.70) and DFS (p = 0.64) were comparable after adjustment for D2 location and adjuvant therapy rate. EN was performed more in American Society of Anesthesiologists (ASA) stage III/IV patients with tumors < 5 cm and was associated with a 5-year OS rate of 84.6%, without any disease recurrences.

conclusionsFor D-GISTs, LR should be the procedure of choice due to lower morbidity and similar oncological outcomes compared with PD. In selected patients, EN appears to be associated with equivalent short- and long-term outcomes. Based on these results, a surgical treatment algorithm is proposed.

Indexed as

Duodenal NeoplasmsGastrointestinal Stromal TumorsCohort StudiesHumansNeoplasm Recurrence, LocalPancreaticoduodenectomyRetrospective StudiesTreatment Outcome

Identifiers

PMID33839975
OpenAlexW3154006122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.